Terms: = Ovarian cancer AND MUC1, PEM, 4582, ENSG00000185499, PUM, MAM6, EMA, CD227, H23AG AND Prognosis
44 results:
1. Primary leiomyosarcoma of ovary: A rare malignancy as an incidental finding.
Raychaudhuri S; Sidam D; Jain M; Chawla R; Pujani M; Wadhwa R
Indian J Pathol Microbiol; 2022; 65(4):938-941. PubMed ID: 36308213
[TBL] [Abstract] [Full Text] [Related]
2. LINC02535/miR-30a-5p/GALNT3 axis contributes to lung adenocarcinoma progression via the NF- κ B signaling pathway.
Li Y; Zhao J; Zhang W; Wang A; Jiao M; Cai X; Zhu J; Liu Z; Huang JA
Cell Cycle; 2022 Dec; 21(23):2455-2470. PubMed ID: 35852407
[TBL] [Abstract] [Full Text] [Related]
3. pumILIO-mediated translational control of somatic cell cycle program promotes folliculogenesis and contributes to ovarian cancer progression.
Li X; Zhu M; Zang M; Cao D; Xie Z; Liang H; Bian Z; Zhao T; Hu Z; Xu EY
Cell Mol Life Sci; 2022 May; 79(5):279. PubMed ID: 35507203
[TBL] [Abstract] [Full Text] [Related]
4. Comprehensive Analysis of Tripterine Anti-ovarian cancer Effects Using Weighted Gene Co-Expression Network Analysis and Molecular Docking.
Long X; Liu L; Zhao Q; Xu X; Liu P; Zhang G; Lin J
Med Sci Monit; 2022 Jan; 28():e932139. PubMed ID: 35022380
[TBL] [Abstract] [Full Text] [Related]
5. Moderately differentiated Sertoli-Leydig cell tumor of ovary with associated mucinous carcinoma and carcinoid-A case report and review of literature.
Ravichandaran A; Lakshmanan A; Kurian A; Prasad S
Indian J Pathol Microbiol; 2021; 64(3):528-531. PubMed ID: 34341265
[TBL] [Abstract] [Full Text] [Related]
6. M2 Macrophages Infiltrating Epithelial ovarian cancer Express MDR1: A Feature That May Account for the Poor prognosis.
Badmann S; Heublein S; Mayr D; Reischer A; Liao Y; Kolben T; Beyer S; Hester A; Zeder-Goess C; Burges A; Mahner S; Jeschke U; Trillsch F; Czogalla B
Cells; 2020 May; 9(5):. PubMed ID: 32429133
[TBL] [Abstract] [Full Text] [Related]
7. Circulating Tumor Cells Characterization Revealed TIMP1 as a Potential Therapeutic Target in ovarian cancer.
Abreu M; Cabezas-Sainz P; Alonso-Alconada L; Ferreirós A; Mondelo-Macía P; Lago-Lestón RM; Abalo A; Díaz E; Palacios-Zambrano S; Rojo-Sebastian A; López-López R; Sánchez L; Moreno-Bueno G; Muinelo-Romay L
Cells; 2020 May; 9(5):. PubMed ID: 32423054
[TBL] [Abstract] [Full Text] [Related]
8. Integrated analysis of gene expression and DNA methylation profiles in ovarian cancer.
Gong G; Lin T; Yuan Y
J Ovarian Res; 2020 Mar; 13(1):30. PubMed ID: 32192517
[TBL] [Abstract] [Full Text] [Related]
9. A 23-Year-Old Joradanian Woman with a Desmoplastic Small Round Cell Tumor Involving the Ovary.
Altal OF; Aleshawi AJ; Tashtush NA; Alhowary A
Am J Case Rep; 2019 Nov; 20():1675-1678. PubMed ID: 31723117
[TBL] [Abstract] [Full Text] [Related]
10. [Un- and dedifferentiated endometrial carcinoma : A rare entity with a wide range of differential diagnosis].
Höhn AK; Brambs CE; Opitz S; Erber R; Hartmann A; Horn LC
Pathologe; 2019 Nov; 40(6):609-618. PubMed ID: 31578630
[TBL] [Abstract] [Full Text] [Related]
11. Humanized anti-Sialyl-Tn antibodies for the treatment of ovarian carcinoma.
Eavarone DA; Al-Alem L; Lugovskoy A; Prendergast JM; Nazer RI; Stein JN; Dransfield DT; Behrens J; Rueda BR
PLoS One; 2018; 13(7):e0201314. PubMed ID: 30052649
[TBL] [Abstract] [Full Text] [Related]
12. ERCC1-expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting post-therapeutic outcome of ovarian cancer.
Chebouti I; Kuhlmann JD; Buderath P; Weber S; Wimberger P; Bokeloh Y; Hauch S; Kimmig R; Kasimir-Bauer S
Oncotarget; 2017 Apr; 8(15):24303-24313. PubMed ID: 28388557
[TBL] [Abstract] [Full Text] [Related]
13. Primary pure spindle cell carcinoma (sarcomatoid carcinoma) of the ovary: A case report with immunohistochemical study.
Giordano G; Berretta R; Silini E
Diagn Pathol; 2016 Aug; 11(1):70. PubMed ID: 27491291
[TBL] [Abstract] [Full Text] [Related]
14. Identification of microRNAs and target genes involved in serous ovarian carcinoma and their influence on survival.
Wang L; Wang B; Fang M; Guo F; Cui M
Eur J Gynaecol Oncol; 2014; 35(6):655-61. PubMed ID: 25556270
[TBL] [Abstract] [Full Text] [Related]
15. ERCC1-positive circulating tumor cells in the blood of ovarian cancer patients as a predictive biomarker for platinum resistance.
Kuhlmann JD; Wimberger P; Bankfalvi A; Keller T; Schöler S; Aktas B; Buderath P; Hauch S; Otterbach F; Kimmig R; Kasimir-Bauer S
Clin Chem; 2014 Oct; 60(10):1282-9. PubMed ID: 25015375
[TBL] [Abstract] [Full Text] [Related]
16. The encouraging prognosis of nongestational ovarian choriocarcinoma with lung metastases.
Liu Y; Yang J; Ren T; Zhao J; Feng F; Wan X; Xiang Y
J Reprod Med; 2014; 59(5-6):221-6. PubMed ID: 24937961
[TBL] [Abstract] [Full Text] [Related]
17. The role of tumour-associated muc1 in epithelial ovarian cancer metastasis and progression.
Deng J; Wang L; Chen H; Li L; Ma Y; Ni J; Li Y
Cancer Metastasis Rev; 2013 Dec; 32(3-4):535-51. PubMed ID: 23609751
[TBL] [Abstract] [Full Text] [Related]
18. Anticancer role of muc1 aptamer-miR-29b chimera in epithelial ovarian carcinoma cells through regulation of PTEN methylation.
Dai F; Zhang Y; Zhu X; Shan N; Chen Y
Target Oncol; 2012 Dec; 7(4):217-25. PubMed ID: 23179556
[TBL] [Abstract] [Full Text] [Related]
19. Systematic analysis and validation of differential gene expression in ovarian serous adenocarcinomas and normal ovary.
Bauerschlag D; Bräutigam K; Moll R; Sehouli J; Mustea A; Salehin D; Krajewska M; Reed JC; Maass N; Hampton GM; Meinhold-Heerlein I
J Cancer Res Clin Oncol; 2013 Feb; 139(2):347-55. PubMed ID: 23090696
[TBL] [Abstract] [Full Text] [Related]
20. Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients.
Scholz C; Heublein S; Lenhard M; Friese K; Mayr D; Jeschke U
BMC Res Notes; 2012 Oct; 5():551. PubMed ID: 23036050
[TBL] [Abstract] [Full Text] [Related]
[Next]
